RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis Meeting Abstract
| Authors: | Cosgriff, T.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Alekseev, B.; Xie, L. P.; Kowalyszyn, R. D.; Karyakin, O.; Neron, Y. V.; Collins, L.; Brechenmacher, T.; Lin, C.; Morgan, L.; Motzer, R. J. |
| Abstract Title: | RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis |
| Meeting Title: | 2016 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2016 Jan 7-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-01-10 |
| Language: | English |
| ACCESSION: | WOS:000378109100553 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2016.34.2_suppl.560 |
| Notes: | Meeting Abstract: 560 -- Source: Wos |
